Acute Respiratory Distress Syndrome (ARDS) Clinical Trials

A listing of Acute Respiratory Distress Syndrome (ARDS) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 325 clinical trials
NHFOV vs NIPPV vs nCPAP in Preterm Infants With Respiratory Distress Syndrome

, controlled trial to test the hypothesis that NHFOV is more effective than nCPAP or NIPPV in the treatment of respiratory distress syndrome (RDS) in infants with a gestational age of less than 30 weeks or a

  • 26 Jan, 2021
  • 8 locations
An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study

findings are consistent with the beneficial effects of lung protective ventilation during the adult respiratory distress syndrome (ARDS). While surgical patients differ substantially from ARDS patients as

  • 25 Feb, 2021
  • 9 locations
Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4)

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients

  • 08 Mar, 2021
  • 41 locations
Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation.

The investigators propose to evaluate premedication with Propofol compared to a control strategy including a placebo with a possible rescue treatment with ketamine to ensure pain control before LISA Procedure . Investigators hypothesize that sedation with Propofol is safe and non-inferior to placebo for the risk of Mechanical Ventilation in …

  • 23 Jan, 2021
  • 15 locations
Integrated Platform for Multimodal Patient Monitoring and Therapy Support in ICU Patients

In neurocritical care, besides the standard intensive care monitoring, even more data are obtained from the very complex pathophysiological changes in brain disease. Medical staff for decision-making cannot integrate the huge amount of clinical data generated every second and visualized on different monitors, anymore. Lack of data integration and usability …

  • 09 Apr, 2021
  • 1 location
Post-Market Study of Low-flow ECCO2R Using PrismaLung+

intended for patients with increased levels of Carbon Dioxide (CO2) in their blood and 18 years old, and will treat patients with mild or moderate acute respiratory distress syndrome (ARDS) using

  • 14 Jun, 2021
  • 1 location
High Flow Nasal Cannula Versus Nasal Intermittent Positive Pressure (NIPPV) in Preterm Infants

intubation when used as primary respiratory support for Respiratory Distress Syndrome (RDS) or post extubation in preterm infants

  • 15 Feb, 2021
  • 1 location
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome

Background: Systemic corticosteroids are considered in patients with an adverse clinical course suffering from conditions like the acute respiratory distress syndrome (ARDS) and septic

organ dysfunction syndrome
  • 07 Nov, 2020
  • 4 locations
Use of Extracorporeal CO2 Removal in Case of Moderate to Severe ARDS to Apply an Ultraprotective Mechanical Ventilation Strategy

The extracorporeal CO2 removal (ECCO2R) has been recently proposed in case of Acute Respiratory Distress Syndrome (ARDS) in order to reduce pulmonary injuries induced by the mechanical

  • 19 Mar, 2021
  • 1 location
Invasive Ventilation for Neonates With Acute Respiratory Distress Syndrome(ARDS)

Acute respiratory distress syndrome (ARDS) in neonates has been defined in 2017.The death rate is over 50%. HFOV and CMV are two main invasive ventilation strategies. However, which one is

acute respiratory distress
assisted breathing
  • 24 Feb, 2021
  • 1 location